Lauren Sabella
Chief Operating Officer presso MANNKIND CORPORATION
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Lauren M.
Sabella is the founder of Tugboat Consulting Group, which was founded in 2009.
She is currently the Chief Operating Officer & Executive Vice President at MannKind Corp.
since 2023.
Ms. Sabella's former positions include Chief Operating Officer at Acorda Therapeutics, Inc. from 2021 to 2022, Vice President-Commercial Development at Altus Pharmaceuticals, Inc. from 2006 to 2008, and Vice President-Sales-Eastern Zone at Boehringer Ingelheim Pharmaceuticals, Inc. from 2002 to 2006.
Ms. Sabella received an undergraduate degree from Hofstra University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
MANNKIND CORPORATION
0.09% | 27/03/2024 | 246 351 ( 0.09% ) | 1 M $ | 31/03/2024 |
| 24/04/2023 | 536 ( 0.04% ) | 7 081 $ | 31/03/2024 |
Posizioni attive di Lauren Sabella
| Società | Posizione | Inizio |
|---|---|---|
| MANNKIND CORPORATION | Chief Operating Officer | 27/03/2023 |
Precedenti posizioni note di Lauren Sabella
| Società | Posizione | Fine |
|---|---|---|
| ACORDA THERAPEUTICS, INC. | Chief Operating Officer | 30/09/2022 |
| Tugboat Consulting Group | Founder | 01/02/2010 |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 30/09/2008 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Sales & Marketing | 01/04/2006 |
Formazione di Lauren Sabella
| Hofstra University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ACORDA THERAPEUTICS, INC. | Health Technology |
| MANNKIND CORPORATION | Health Technology |
| Aziende private | 3 |
|---|---|
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
| Tugboat Consulting Group |
- Borsa valori
- Insiders
- Lauren Sabella
